Akebia Therapeutics, Inc. (AKBA) ownership: Top institutional holder: BlackRock, Inc. ($25.98M). Insider activity: Net Seller (1 buys, 19 sells). SEC EDGAR first-party data.
| Holder | Shares | Market Value | Reported |
|---|---|---|---|
| BlackRock, Inc. | 18693296.00 | $25.98M | 2026-03-31 |
| VANGUARD GROUP INC | 16016448.00 | $25.79M | 2025-12-31 |
| BlackRock Fund Advisors | 1703987.00 | $17.74M | 2016-12-31 |
| STATE STREET CORP | 11614006.00 | $16.14M | 2026-03-31 |
| VANGUARD CAPITAL MANAGEMENT LLC | 11166710.00 | $15.52M | 2026-03-31 |
| GEODE CAPITAL MANAGEMENT, LLC | 6452252.00 | $8.97M | 2026-03-31 |
| GOLDMAN SACHS GROUP INC | 3602827.00 | $5.01M | 2026-03-31 |
| CITIGROUP INC | 2854586.00 | $3.97M | 2026-03-31 |
| Insider | Transaction | Value | Date |
|---|---|---|---|
| Sell | null | 2026-06-17 | |
| Sell | null | 2026-06-17 | |
| Sell | null | 2026-06-17 | |
| Sell | null | 2026-06-17 | |
| Sell | null | 2026-06-17 | |
| Sell | null | 2026-06-17 | |
| Sell | null | 2026-06-17 | |
| Sell | null | 2026-06-17 |
Back to AKBA overview · AKBA earnings · All congressional trades
Institutional data from SEC Form 13F. Insider data from SEC Form 4. Congressional data from STOCK Act disclosures. Not personalized investment advice.